Indian court grants temporary relief to Abbott, Glenmark in drug ban case

Abbott India

15/03/2016 11:12

NEW DELHI, March 15 (Reuters) - An Indian court on Tuesday 
granted interim injunction to U.S. drugmaker Abbott's India unit 
 ABOT.NS , and domestic companies Glenmark Pharmaceuticals 
 GLEN.NS  and Macleods Pharmaceuticals, on the prohibition on 
sale of several combination drugs. 
    India banned 344 drug combinations over the weekend, 
including Abbott's codeine-based cough syrup, after a government 
panel of experts found they had "no therapeutic justification." 
 urn:newsml:reuters.com:*:nL3N16M1CY 
    The judge in the Delhi High court granted an interim stay to 
the pharmaceutical companies and said regulators should take "no 
coercive steps" against them. The case will now be heard on 
March 21.  
    The Indian unit of U.S. drugmaker Pfizer  PFE.N   PFIZ.NS  
had on Monday won a similar reprieve on a ban on its popular 
cough syrup Corex.  urn:newsml:reuters.com:*:nL3N16M1SX 
 
 (Reporting by Suchitra Mohanty; Editing by Sumeet Chatterjee) 
 ((aditya.kalra@thomsonreuters.com; +91-011-41781009; Reuters 
Messaging: aditya.kalra.thomsonreuters.com@reuters.net)(Twitter: 
@adityakalra)) 
 
Keywords: INDIA MEDICINE/